Stryker Corporation (SYK)
NYSE • Healthcare
October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Stryker Corporation keeps $19 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 29
in 25 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Stryker Corporation beat expectations on both the top and bottom line in the second fiscal quarter of 2026, with results reported July 30 based on preliminary figures. Revenue rose 9% to about $6.6 billion, edging the $6.6 billion estimate by 0.1%, while adjusted EPS of $3.69 topped the $3.49 consensus by 5.7%. Net income climbed 44% to about $1.3 billion from $884.0 million a year ago, with gross margin near 68% and operating margin about 25%. Revenue growth was led by MedSurg and Neurotechnology, the largest segment at about $3.2 billion, up 5%, while the United States remained the largest region at about $4.5 billion, up 1%. Stryker also generated operating cash flow of $581.0 million, repurchased $139.0 million of stock, and paid $337.0 million in dividends. Consensus for the next period calls for EPS of $3.68 on revenue of $6.72 billion.
Next report — what to expect
Stryker Corporation (SYK) reports next on October 29, 2026. Wall Street’s consensus calls for EPS of $3.61 on revenue of $6.65 billion. For trailing context, revenue grew 9.4% year over year last quarter. Stryker has beaten EPS in 7 of 8 most recent quarters, making any deviation from that pattern notable.
About Stryker Corporation
Stryker Corporation (NYSE: SYK) makes medical devices for orthopaedic, surgical, neurotechnology, and emergency-care settings. In healthcare, it sells implants for joint replacement procedures, trauma and extremity products, spinal systems, and hospital equipment, and it recorded $25.1 billion of revenue in FY2025.
Today's Snapshot
SYK closed 0.9% higher at 275.46, while its sector was flat. Volume was about two-thirds of its usual level.
Trading Volume
Below 10d avg (2.5M)
1.4M
vs S&P 500 Today
Moderate Outperformance
+0.14%
Updated: October 2, 2026 at 20:06 UTC
SYK Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$276.03 - $329.53Sell
- RSI (14)38.14Neutral
- Stochastic %K (14, 3, 3)28.72Neutral
- MACD Level (12, 26)-10.11Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.